EW
Eric Weisblum
Chief Executive OfficerDirector

Eric Weisblum insider trades: Silo Pharma (SILO) stock purchases

Chief Executive Officer, Silo Pharma Last trade Dec 15, 2025 29 Form 4 filings
$0
Sold, last 12 months
0 sales
$8K
Bought, last 12 months
3 buys
22
Open-market trades
since 2019
4
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Eric reports to the SEC

Open-market buys and sales

22 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 15, 2025SILO↑ Buy$2K
Nov 21, 2025SILO↑ Buy$735
Nov 19, 2025SILO↑ Buy$5K
May 27, 2025SILO↑ Buy$4K
Dec 13, 2024SILO↑ Buy$2K
Nov 22, 2024SILO↑ Buy$5K
Jun 12, 2024SILO↑ Buy$6K
Apr 5, 2024SILO↑ Buy$2K
Apr 1, 2024SILO↑ Buy$9K
Dec 20, 2023SILO↑ Buy$1K
Dec 15, 2023SILO↑ Buy$2K
Dec 7, 2023SILO↑ Buy$1K
Nov 30, 2023SILO↑ Buy$3K
Nov 27, 2023SILO↑ Buy$1K
Nov 21, 2023SILO↑ Buy$7K
Nov 17, 2023SILO↑ Buy$4K
May 18, 2023SILO↑ Buy$6K
Dec 20, 2022SILO↑ Buy$890
Dec 14, 2022SILO↑ Buy$2K
Jun 17, 2022SILO↑ Buy$2K
Dec 13, 2021SILO↑ Buy$3K
Oct 22, 2019SILO↑ Buy$281

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Eric Weisblum's insider trades

Eric Weisblum is Chief Executive Officer at Silo Pharma (SILO). Since Oct 22, 2019, Eric has reported 22 open-market purchases worth $69K and no sales on SEC Form 4. In the last 12 months: 3 buys ($8K).

Their filings also include grants and awards (7 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SILO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.